Showing results (261-270 of 316) with videos related to

Sort By:
Pageof 32
Surgery|May 13, 2018
The rate of false-positive diagnosis of colorectal liver metastases in patients undergoing resection with the development of a novel, externally validated risk scoreDavid J O'Reilly, James Hodson, Thomas W Pike, et al.
The British Journal of Surgery|March 21, 2018
Operating list composition and surgical performanceT W Pike, F Mushtaq, R P Mann, et al.
Annals of Surgery|July 26, 2005
Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current roleHideki Nishio, Ernest Hidalgo, Zaed Z R Hamady, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 7, 2007
Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcomeZ Z R Hamady, H Z Malik, N Alwan, et al.
Radiology|January 8, 2020
The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer TherapyPaul E Kinahan, Eric S Perlman, John J Sunderland, et al.
Surgery|May 29, 2017
Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factorsNorihisa Kimura, Alastair L Young, Yoshikazu Toyoki, et al.
Inflammatory Bowel Diseases|August 11, 2011
Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1Zaed Z R Hamady, Nigel Scott, Mark D Farrar, et al.
European Journal of Gastroenterology & Hepatology|July 23, 2014
Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?Abdul R Hakeem, Gabriele Marangoni, Stephen J Chapman, et al.
The Prostate|May 6, 1998
Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)M L Salgaller, P A Lodge, J G McLean, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2003
Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imagingSusan M Galbraith, Ross J Maxwell, Martin A Lodge, et al.
Pageof 32